<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
Key Points Some 10.1% of adults with non–Langerhans cell histiocytosis have a concomitant myeloid neoplasm with each often harboring distinct mutations. The presence of distinct kinase mutations in histiocytosis and myeloid neoplasms resulted in discordant responses to targeted therapy.
Adult, Male, Erdheim-Chester Disease, Histiocytosis, Non-Langerhans-Cell, [SDV]Life Sciences [q-bio], 610, Middle Aged, [SDV] Life Sciences [q-bio], Prevalence, Humans, Female, Molecular Targeted Therapy, Bone Marrow Neoplasms, Aged
Adult, Male, Erdheim-Chester Disease, Histiocytosis, Non-Langerhans-Cell, [SDV]Life Sciences [q-bio], 610, Middle Aged, [SDV] Life Sciences [q-bio], Prevalence, Humans, Female, Molecular Targeted Therapy, Bone Marrow Neoplasms, Aged
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 117 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |